FDA Approves Bimekizumab for Plaque Psoriasis UCB announced today that the FDA has approved bimekizumab-bkzx (Bimzelx)) for the treatment of moderate to severe plaque psoriasis in adults who needing systemic therapy or phototherapy. https://t.co/BqeSAAxtQb https://t.co/LFjzkmAC5w